Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 642.25
(-1.17%)
INR 642.25
(-1.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.25 Billion INR | 22.7% |
| 2022 | 6.72 Billion INR | 7886951.37% |
| 2021 | 85.26 Thousand INR | -63.36% |
| 2020 | 232.71 Thousand INR | 24.61% |
| 2019 | 186.75 Thousand INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 9.19 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 8.25 Billion INR | 22.7% |
| 2023 Q2 | 6.55 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 8.25 Billion INR | 0.0% |
| 2022 FY | 6.72 Billion INR | 7886951.37% |
| 2022 Q4 | 6.72 Billion INR | -5.1% |
| 2022 Q3 | 7.08 Billion INR | 0.0% |
| 2021 Q1 | 130.78 Thousand INR | 0.0% |
| 2021 FY | 85.26 Thousand INR | -63.36% |
| 2021 Q4 | 6.53 Billion INR | -0.0% |
| 2021 Q3 | 6.53 Billion INR | 4996013.5% |
| 2021 Q2 | 130.78 Thousand INR | 0.0% |
| 2020 FY | 232.71 Thousand INR | 24.61% |
| 2019 FY | 186.75 Thousand INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 49.301% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 94.579% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | -59.252% |
| Granules India Limited | 22.95 Billion INR | 64.056% |
| Indoco Remedies Limited | 10.34 Billion INR | 20.224% |
| Achyut Healthcare Limited | 2.01 Million INR | -409770.84% |
| Ajanta Pharma Limited | 10.71 Billion INR | 22.965% |
| Alkem Laboratories Limited | 48.6 Billion INR | 83.025% |
| Alpa Laboratories Limited | 307.12 Million INR | -2586.457% |
| Brooks Laboratories Limited | 248.6 Million INR | -3218.852% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | -125.361% |
| Bajaj HealthCare Limited | 4.86 Billion INR | -69.5% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -291.241% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 92.287% |
| Eris Lifesciences Limited | 38.26 Billion INR | 78.44% |
| FDC Limited | 3.7 Billion INR | -122.438% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 87.328% |
| Gufic Biosciences Limited | 5.59 Billion INR | -47.339% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -260.377% |
| Ipca Laboratories Limited | 33.74 Billion INR | 75.548% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -2680.26% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | -177.436% |
| Lasa Supergenerics Limited | 541.92 Million INR | -1422.48% |
| Laurus Labs Limited | 42.71 Billion INR | 80.684% |
| Lupin Limited | 96.23 Billion INR | 91.427% |
| Mankind Pharma Limited | 23.87 Billion INR | 65.442% |
| Medicamen Biotech Limited | 940.36 Million INR | -777.391% |
| Medico Remedies Limited | 438.24 Million INR | -1782.673% |
| Megasoft Limited | 1.85 Billion INR | -345.227% |
| NATCO Pharma Limited | 10.53 Billion INR | 21.661% |
| Piramal Pharma Limited | 74 Billion INR | 88.851% |
| RPG Life Sciences Limited | 1.38 Billion INR | -497.79% |
| Sigachi Industries Limited | 2.53 Billion INR | -225.952% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 95.505% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -305.593% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -608.086% |
| Unichem Laboratories Limited | 8.06 Billion INR | -2.249% |
| Wanbury Limited | 3.15 Billion INR | -161.469% |
| Windlas Biotech Limited | 1.76 Billion INR | -368.072% |
| ZIM Laboratories Limited | 2.08 Billion INR | -296.523% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 88.507% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | -111.942% |
| Divi's Laboratories Limited | 18.99 Billion INR | 56.552% |
| Hester Biosciences Limited | 3.59 Billion INR | -129.523% |
| Procter & Gamble Health Limited | 2.56 Billion INR | -222.142% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -952.622% |
| Bal Pharma Limited | 2.51 Billion INR | -228.546% |
| Strides Pharma Science Limited | 37.68 Billion INR | 78.104% |
| Venus Remedies Limited | 1.39 Billion INR | -492.382% |
| Nectar Lifesciences Limited | 11.21 Billion INR | 26.452% |
| Shilpa Medicare Limited | 12.93 Billion INR | 36.202% |
| Aarti Drugs Limited | 11.5 Billion INR | 28.28% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | -30.365% |
| Suven Life Sciences Limited | 148.62 Million INR | -5451.503% |
| Ind-Swift Limited | 13.45 Billion INR | 38.67% |
| Valiant Laboratories Limited | 1.05 Billion INR | -679.648% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 22.948% |
| Solara Active Pharma Sciences Limited | 14.14 Billion INR | 41.666% |
| Themis Medicare Limited | 1.88 Billion INR | -337.121% |
| Hikal Limited | 12.99 Billion INR | 36.508% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 89.944% |
| Sequent Scientific Limited | 8.27 Billion INR | 0.285% |
| Novartis India Limited | 1.8 Billion INR | -358.092% |
| Wockhardt Limited | 39.87 Billion INR | 79.306% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 86.535% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -2756.9% |
| Neuland Laboratories Limited | 5.49 Billion INR | -50.052% |
| Morepen Laboratories Limited | 4.45 Billion INR | -85.002% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -1181.397% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -317.48% |